REFERENCES
1. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. The Lancet 2020;395:200-11.
2. Zhang W, Jiang H, Wu G, et al. The pathogenesis and potential therapeutic targets in sepsis. MedComm 2023;4:e418.
3. Katsounas A, Tsochatzis E, Rello J. Sepsis-associated liver injury: from liver-test risk signals to immunobiology-guided precision medicine. Intensive Care Med 2026.
4. Guo Y, Guo W, Chen H, Sun J, Yin Y. Mechanisms of sepsis-induced acute liver injury: a comprehensive review. Front Cell Infect Microbiol 2025;15:1504223.
5. Sun J, Zhang J, Wang X, et al. Gut-liver crosstalk in sepsis-induced liver injury. Crit Care 2020;24:3327.
6. Xu X, Yang T, An J, Li B, Dou Z. Liver injury in sepsis: manifestations, mechanisms and emerging therapeutic strategies. Front Immunol 2025;16:1575554.
7. Strnad P, Tacke F, Koch A, Trautwein C. Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol 2017;14:55-66.
9. Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunction in critical illness. Crit Care Clin 2016;32:203-12.
10. Zheng L, Jia T, Li Y, Zhang Z, Su H, Zhang R. The interplay between gastrointestinal dysfunction and gut microbiota dynamics in sepsis. Front Cell Infect Microbiol 2026;16:1761536.
11. Shahid A, Chambers S, Scott-Thomas A, Bhatia M. Gut microbiota and liver dysfunction in sepsis: the role of inflammatory mediators and therapeutic approaches. Int J Mol Sci 2024;25:13415.
12. Murao A, Jha A, Kato T, et al. Gut-primed neutrophils activate Kupffer cells to promote hepatic injury in mouse sepsis. Nat Commun 2025;16:65572.
13. Pabst O, Hornef MW, Schaap FG, Cerovic V, Clavel T, Bruns T. Gut-liver axis: barriers and functional circuits. Nat Rev Gastroenterol Hepatol 2023;20:447-61.
14. Bauer M. The liver-gut-axis: initiator and responder to sepsis. Curr Opin Crit Care 2022;28:216-20.
15. Margutti P, D’Ambrosio A, Zamboni S. Microbiota-derived extracellular vesicle as emerging actors in host interactions. Int J Mol Sci 2024;25:8722.
16. Ma K, Zhang Q, Jin Z, et al. Gut microbiota-derived extracellular vesicles: bridging microbial-host crosstalk in metabolic disorders. Cell Commun Signal 2026;24:3034.
17. Li Y, Li J, Dullaart R, Moshage H. Bacterial extracellular vesicles in the pathogenesis and treatment of liver diseases. J Gastroenterol Hepatol 2026;41:880-94.
18. Jain H, Kumar A, Almousa S, et al. Characterisation of LPS+ bacterial extracellular vesicles along the gut-hepatic portal vein-liver axis. J Extracell Vesicles 2024;13:e12474.
19. Effah CY, Ding X, Drokow EK, Li X, Tong R, Sun T. Bacteria-derived extracellular vesicles: endogenous roles, therapeutic potentials and their biomimetics for the treatment and prevention of sepsis. Front Immunol 2024;15:1296061.
20. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016;315:801.
21. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009;9:799-809.
22. Haussner F, Chakraborty S, Halbgebauer R, Huber-Lang M. Challenge to the intestinal mucosa during sepsis. Front Immunol 2019;10:891.
24. Dixon LJ, Barnes M, Tang H, Pritchard MT, Nagy LE. Kupffer cells in the liver. Compr Physiol 2013;3:785-97.
25. Beyer D, Hoff J, Sommerfeld O, Zipprich A, Gaßler N, Press AT. The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation. Mol Med 2022;28:510.
26. Zhang X, Liu H, Hashimoto K, Yuan S, Zhang J. The gut-liver axis in sepsis: interaction mechanisms and therapeutic potential. Crit Care 2022;26:4090.
27. Zhang D, Li Y, Ding L, Fu Y, Dong X, Li H. Prevalence and outcome of acute gastrointestinal injury in critically ill patients: a systematic review and meta-analysis. Medicine 2018;97:e12970.
28. Kobashi H, Toshimori J, Yamamoto K. Sepsis-associated liver injury: Incidence, classification and the clinical significance. Hepatol Res 2013;43:255-66.
29. Zhai R, Sheu CC, Su L, et al. Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis. Thorax 2009;64:784-90.
30. Blot S, Antonelli M, Arvaniti K, et al. ; the Abdominal Sepsis Study (AbSeS) group on behalf of the Trials Group of the European Society of Intensive Care Medicine. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project. Intensive Care Med 2019;45:1703-17.
31. Meng M, Klingensmith NJ, Coopersmith CM. New insights into the gut as the driver of critical illness and organ failure. Curr Opin Crit Care 2017;23:143-8.
32. Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nat Rev Microbiol 2019;17:13-24.
33. Schwechheimer C, Kuehn MJ. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat Rev Microbiol 2015;13:605-19.
34. Brown L, Wolf JM, Prados-Rosales R, Casadevall A. Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat Rev Microbiol 2015;13:620-30.
35. Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol 2010;64:163-84.
36. Liu BD, Akbar R, Oliverio A, Thapa K, Wang X, Fan G. Bacterial extracellular vesicles in the regulation of inflammatory response and host-microbe interactions. Shock 2024;61:175-88.
37. Gilmore WJ, Johnston EL, Zavan L, Bitto NJ, Kaparakis-Liaskos M. Immunomodulatory roles and novel applications of bacterial membrane vesicles. Mol Immunol 2021;134:72-85.
38. Cao Y, Lin H. Characterization and function of membrane vesicles in Gram-positive bacteria. Appl Microbiol Biotechnol 2021;105:1795-801.
39. Feuillet V, Medjane S, Mondor I, et al. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc Natl Acad Sci U S A 2006;103:12487-92.
40. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-8.
41. Charpentier LA, Dolben EF, Hendricks MR, Hogan DA, Bomberger JM, Stanton BA. Bacterial outer membrane vesicles and immune modulation of the host. Membranes 2023;13:752.
42. Thapa HB, Kohl P, Zingl FG, et al. Characterization of the inflammatory response evoked by bacterial membrane vesicles in intestinal cells reveals an RIPK2-dependent activation by enterotoxigenic Escherichia coli vesicles. Microbiol Spectr 2023;11:e01115-23.
43. Liang L, Yang C, Liu L, et al. Commensal bacteria-derived extracellular vesicles suppress ulcerative colitis through regulating the macrophages polarization and remodeling the gut microbiota. Microb Cell Fact 2022;21:1812.
44. Yerneni SS, Werner S, Azambuja JH, et al. Pneumococcal extracellular vesicles modulate host immunity. mBio 2021;12:e01657-21.
45. Toyofuku M, Schild S, Kaparakis-Liaskos M, Eberl L. Composition and functions of bacterial membrane vesicles. Nat Rev Microbiol 2023;21:415-30.
46. Koeppen K, Hampton TH, Jarek M, et al. A novel mechanism of host-pathogen interaction through sRNA in bacterial outer membrane vesicles. PLoS Pathog 2016;12:e1005672.
47. Plovier H, Everard A, Druart C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med 2017;23:107-13.
48. Mottawea W, Yousuf B, Sultan S, et al. Multi-level analysis of gut microbiome extracellular vesicles-host interaction reveals a connection to gut-brain axis signaling. Microbiol Spectr 2025;13:e01368-24.
49. Huang J, Yu Y, Feng Z, et al. Cross-Kingdom dialogue of microbial messengers: multi-target regulatory mechanisms and therapeutic strategies of gut microbiota-derived extracellular vesicles in metabolic diseases. Int J Nanomedicine 2025;20:12573-91.
50. Jan AT. Outer membrane vesicles (OMVs) of Gram-negative bacteria: a perspective update. Front Microbiol 2017;8:1053.
51. Zhou Y, Sun Y, Yin P, Zuo S, Li H, Cao K. Bacterial extracellular vesicles: emerging mediators of gut-liver axis crosstalk in hepatic diseases. Front Cell Infect Microbiol 2025;15:1620829.
52. Kaparakis-Liaskos M, Ferrero RL. Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol 2015;15:375-87.
53. Takeuchi O, Hoshino K, Kawai T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999;11:443-51.
54. Erttmann SF, Swacha P, Aung KM, et al. The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis. Immunity 2022;55:847-61.e10.
55. Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent J. Sepsis and septic shock. Nat Rev Dis Primers 2016;2:BFnrdp201645.
56. Tulkens J, Vergauwen G, Van Deun J, et al. Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction. Gut 2020;69:191-3.
57. McBroom AJ, Kuehn MJ. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol Microbiol 2007;63:545-58.
58. Appiah MG, Park EJ, Darkwah S, et al. Intestinal epithelium-derived luminally released extracellular vesicles in sepsis exhibit the ability to suppress TNF-α and IL-17A expression in mucosal inflammation. Int J Mol Sci 2020;21:8445.
59. Li P, Wu Y, Goodwin AJ, et al. Circulating extracellular vesicles are associated with the clinical outcomes of sepsis. Front Immunol 2023;14:1150564.
60. Rodríguez-Díaz C, Martín-Reyes F, Taminiau B, et al. The metagenomic composition and effects of fecal-microbe-derived extracellular vesicles on intestinal permeability depend on the patient’s disease. Int J Mol Sci 2023;24:4971.
61. Lankelma JM, van Vught LA, Belzer C, et al. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study. Intensive Care Med 2017;43:59-68.
62. McDonald D, Ackermann G, Khailova L, et al. Extreme dysbiosis of the microbiome in critical illness. mSphere 2016;1:e00199-16.
63. Liang H, Song H, Zhang X, et al. Metformin attenuated sepsis-related liver injury by modulating gut microbiota. Emerg Microbes Infect 2022;11:815-28.
64. Becattini S, Taur Y, Pamer EG. Antibiotic-induced changes in the intestinal microbiota and disease. Trends Mol Med 2016;22:458-78.
65. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011;108:4554-61.
66. Lee E, Choi D, Kim K, Gho YS. Proteomics in gram-negative bacterial outer membrane vesicles. Mass Spectrom Rev 2008;27:535-55.
67. Stentz R, Jones E, Juodeikis R, et al. The proteome of extracellular vesicles produced by the human gut bacteria Bacteroides thetaiotaomicron in vivo is influenced by environmental and host-derived factors. Appl Environ Microbiol 2022;88:e00533-22.
68. Odenwald MA, Turner JR. The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol 2017;14:9-21.
69. Oami T, Shimazui T, Yumoto T, Otani S, Hayashi Y, Coopersmith CM. Gut integrity in intensive care: alterations in host permeability and the microbiome as potential therapeutic targets. J intensive care 2025;13:786.
70. Marchiando AM, Shen L, Graham WV, et al. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 2010;189:111-26.
71. Sun S, Duan Z, Wang X, et al. Neutrophil extracellular traps impair intestinal barrier functions in sepsis by regulating TLR9-mediated endoplasmic reticulum stress pathway. Cell Death Dis 2021;12:3896.
72. Cao Y, Zhang Y, Gerile W, et al. PLK1 protects intestinal barrier function during sepsis by targeting mitochondrial dynamics through TANK-NF-κB signalling. Mol Med 2022;28:597.
73. Chu C, Wang X, Chen F, et al. Neutrophil extracellular traps aggravate intestinal epithelial necroptosis in ischaemia-reperfusion by regulating TLR4/RIPK3/FUNDC1 -required mitophagy. Cell Prolif 2024;57:e13538.
74. Zuo L, Kuo W, Turner JR. Tight junctions as targets and effectors of mucosal immune homeostasis. Cell Mol Gastroenterol Hepatol 2020;10:327-40.
75. Oami T, Abtahi S, Shimazui T, et al. Claudin-2 upregulation enhances intestinal permeability, immune activation, dysbiosis, and mortality in sepsis. Proc Natl Acad Sci U S A 2024;121:e2217877121.
76. Yoseph BP, Klingensmith NJ, Liang Z, et al. Mechanisms of intestinal barrier dysfunction in sepsis. Shock 2016;46:52-9.
77. Hundscheid IH, Grootjans J, Lenaerts K, et al. The human colon is more resistant to ischemia-reperfusion-induced tissue damage than the small intestine: an observational study. Ann Surg 2015;262:304-11.
78. Elmi A, Nasher F, Jagatia H, et al. Campylobacter jejuni outer membrane vesicle-associated proteolytic activity promotes bacterial invasion by mediating cleavage of intestinal epithelial cell E-cadherin and occludin. Cell Microbiol 2016;18:561-72.
79. Jang SC, Kim SR, Yoon YJ, et al. In vivo kinetic biodistribution of nano-sized outer membrane vesicles derived from bacteria. Small 2015;11:456-61.
80. Hu Q, Ren H, Li G, et al. STING-mediated intestinal barrier dysfunction contributes to lethal sepsis. EBioMedicine 2019;41:497-508.
81. Díaz-Garrido N, Badia J, Baldomà L. Microbiota-derived extracellular vesicles in interkingdom communication in the gut. J Extracell Vesicles 2021;10:e12161.
82. Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol 2016;17:564-80.
83. Gilmore WJ, Johnston EL, Bitto NJ, et al. Bacteroides fragilis outer membrane vesicles preferentially activate innate immune receptors compared to their parent bacteria. Front Immunol 2022;13:970725.
84. O’Donoghue EJ, Sirisaengtaksin N, Browning DF, et al. Lipopolysaccharide structure impacts the entry kinetics of bacterial outer membrane vesicles into host cells. PLoS Pathog 2017;13:e1006760.
85. Olofsson A, Nygård Skalman L, Obi I, Lundmark R, Arnqvist A. Uptake of Helicobacter pylori vesicles is facilitated by clathrin-dependent and clathrin-independent endocytic pathways. mBio 2014;5:e00979-14.
86. Rubio APD, Martínez J, Palavecino M, et al. Transcytosis of Bacillus subtilis extracellular vesicles through an in vitro intestinal epithelial cell model. Sci Rep 2020;10:3120.
87. O’Donoghue EJ, Krachler AM. Mechanisms of outer membrane vesicle entry into host cells: microReview - OMV entry into host cells. Cell Microbiol 2016;18:1508-17.
89. Pool R, Gomez H, Kellum JA. Mechanisms of organ dysfunction in sepsis. Crit Care Clin 2018;34:63-80.
90. Wang G, Jin S, Huang W, et al. LPS-induced macrophage HMGB1-loaded extracellular vesicles trigger hepatocyte pyroptosis by activating the NLRP3 inflammasome. Cell Death Discov 2021;7:729.
91. Luo Z, Ji Y, Gao H, et al. CRIg+ macrophages prevent gut microbial DNA-containing extracellular vesicle-induced tissue inflammation and insulin resistance. Gastroenterology 2021;160:863-74.
92. Luo Z, Ji Y, Zhang D, et al. Microbial DNA enrichment promotes liver steatosis and fibrosis in the course of non-alcoholic steatohepatitis. Acta Physiol 2022;235:e13827.
93. Qin X, Wang S, Yan Z, Zhao N, Yao J. The role of bacterial outer membrane vesicles in inflammatory response of acute-on-chronic liver failure. Front Microbiol 2025;16:1608137.
94. Gong Y, Jin L, Duan L, et al. Extracellular vesicles derived from Streptococcus anginosus aggravate lupus nephritis by triggering TLR2-MyD88-NF-κB signalling in NK cells. J Extracell Vesicles 2025;14:e70134.
95. Engevik MA, Danhof HA, Ruan W, et al. Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation. mBio 2021;12:e02706-20.
97. Fleetwood AJ, Lee MKS, Singleton W, et al. Metabolic remodeling, inflammasome activation, and pyroptosis in macrophages stimulated by Porphyromonas gingivalis and its outer membrane vesicles. Front Cell Infect Microbiol 2017;7:351.
98. Guo J, Friedman SL. Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair 2010;3:36.
99. Fizanne L, Villard A, Benabbou N, et al. Faeces-derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases. J Extracell Vesicles 2023;12:12303.
101. Han E, Choi S, Lee Y, Park J, Hong S, Lee H. Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF-α production in human macrophages and cross the blood-brain barrier in mice. FASEB J 2019;33:13412-22.
102. Guangzhang C, Fangfang F, Siqian D, et al. Outer membrane vesicles from Escherichia coli are efficiently internalized by macrophage cells and alter their inflammatory response. Microb Pathog 2023;175:105965.
103. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-84.
104. Fonseca S, Carvalho AL, Miquel-Clopés A, et al. Extracellular vesicles produced by the human gut commensal bacterium Bacteroides thetaiotaomicron elicit anti-inflammatory responses from innate immune cells. Front Microbiol 2022;13:1050271.
105. Durant L, Stentz R, Noble A, et al. Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease. Microbiome 2020;8:868.
106. Shen Y, Torchia M, Lawson G, Karp C, Ashwell J, Mazmanian S. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe 2012;12:509-20.
107. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008;453:620-5.
108. Kim W, Lee EJ, Bae I, et al. Lactobacillus plantarum -derived extracellular vesicles induce anti-inflammatory M2 macrophage polarization in vitro. J Extracell Vesicles 2020;9:1793514.
109. Feng Y, Luo S, Fang C, et al. ANGPTL8 deficiency attenuates lipopolysaccharide-induced liver injury by improving lipid metabolic dysregulation. J Lipid Res 2024;65:100595.
110. Van Wyngene L, Vanderhaeghen T, Timmermans S, et al. Hepatic PPARα function and lipid metabolic pathways are dysregulated in polymicrobial sepsis. EMBO Mol Med 2020;12:BFEMMM201911319.
111. Akazawa Y, Nakao K. Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors. Hepatol Res 2016;46:977-84.
112. Karagöz GE, Acosta-Alvear D, Walter P. The unfolded protein response: detecting and responding to fluctuations in the protein-folding capacity of the Endoplasmic reticulum. Cold Spring Harb Perspect Biol 2019;11:a033886.
113. Yang J, Hwang I, Lee E, et al. Bacterial outer membrane vesicle-mediated cytosolic delivery of flagellin triggers host NLRC4 canonical inflammasome signaling. Front Immunol 2020;11:581165.
114. Deo P, Chow SH, Han M, et al. Mitochondrial dysfunction caused by outer membrane vesicles from Gram-negative bacteria activates intrinsic apoptosis and inflammation. Nat Microbiol 2020;5:1418-27.
115. Vanaja S, Russo A, Behl B, et al. Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation. Cell 2016;165:1106-19.
116. Liu L, Liang L, Yang C, Zhou Y, Chen Y. Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway. Gut Microbes 2021;13:1-20.
117. Nie Y, Xie X, Zhou L, et al. Desulfovibrio fairfieldensis-derived outer membrane vesicles damage epithelial barrier and induce inflammation and pyroptosis in macrophages. Cells 2023;12:89.
118. Su K, Koh Kok J, Chua Y, et al. Bacterial extracellular vesicles in biofluids as potential diagnostic biomarkers. Expert Rev Mol Diagn 2022;22:1057-62.
119. Michel LV, Gaborski T. Outer membrane vesicles as molecular biomarkers for Gram-negative sepsis: Taking advantage of nature’s perfect packages. J Biol Chem 2022;298:102483.
120. Li Q, Ou Z, Lin J, et al. Specific labeling of outer membrane vesicles with antibiotic-conjugated probe reveals early bacterial infections in blood. Nat Commun 2025;16:58676.
121. Welsh JA, Goberdhan DCI, O’Driscoll L, et al. ; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 2024;13:e12404.
122. Schwechheimer C, Kulp A, Kuehn MJ. Modulation of bacterial outer membrane vesicle production by envelope structure and content. BMC Microbiol 2014;14:324.
123. Steenhuis M, ten Hagen-jongman CM, van Ulsen P, Luirink J. Stress-based high-throughput screening assays to identify inhibitors of cell envelope biogenesis. Antibiotics 2020;9:808.
124. Zhao Q, Lai J, Jiang Y, et al. Lactiplantibacillus plantarum -derived extracellular vesicles alleviate acute lung injury by inhibiting ferroptosis of macrophages. J Nanobiotechnol 2025;23:3405.
125. Mandelbaum N, Zhang L, Carasso S, et al. Extracellular vesicles of the Gram-positive gut symbiont Bifidobacterium longum induce immune-modulatory, anti-inflammatory effects. npj Biofilms Microbiomes 2023;9:400.
126. Nie X, Li Q, Ji H, et al. Bifidobacterium longum NSP001-derived extracellular vesicles ameliorate ulcerative colitis by modulating T cell responses in gut microbiota-(in)dependent manners. npj Biofilms Microbiomes 2025;11:27.




